3Cushnaghan J,Dieppe P. Study of 500 patients with limb joint osteoarthritis.I.Analysis by age.sex.and distribution of symptomatic joint sites[J].{H}ANNALS OF THE RHEUMATIC DISEASES,1991,(01):8-13.
4Adebajo AO. Pattern of osteoarthritis in a West African teaching hospital[J].{H}ANNALS OF THE RHEUMATIC DISEASES,1991,(01):20-22.
5Eljaafari A,Tartelin ML,Aissaoui H. Bone marrow-derived and synovium-derived mesenchymal cells promote Th17 cellexpansion and activation through caspase 1 activation:contribution to the chronicity of rheumatoid arthritis[J].{H}ARTHRITIS AND RHEUMATISM,2012,(07):2147-2157.
6Filardo G,Madry H,Jelic M. Mesenchymal stem cells for the treatment of cartilage lesions:from preclinical findings toclinical application in orthopaedics[J].{H}Knee Surgery Sports Traumatology Arthroscopy,2013,(08):1717-1729.
7MacFarlane RJ,Graham SM,Davies PS. Anti-inflammatory role and immunomodulation of mesenchymal stem cells in systemic joint diseases:potential for treatment[J].{H}EXPERT OPINION ON THERAPEUTIC TARGETS,2013,(03):243-254.
8Veronesi F,Giavaresi G,Tschon M. Clinical use of bone marrow,bone marrow concentrate,and expanded bone marrowmesenchymal stem cells in cartilage disease[J].{H}STEM CELLS AND DEVELOPMENT,2013,(02):181-192.
9Diekman BO,Wu CL,Louer CR. Intra-articular delivery of purified mesenchymal stem cells from C57BL/6 or MRL/MpJ superhealer mice prevents posttraumatic arthritis[J].cellTransplant,2013,(08):1395-1408.
10Zhou S,Glowacki J,Kim SW. Clinical characteristics influence in vitro action of 1,25-dihydroxyvitamin D(3)in human marrowstromal cells[J].{H}Journal of Bone and Mineral Research,2012,(09):1992-2000.
